When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Cass Review - Wikipedia

    en.wikipedia.org/wiki/Cass_Review

    Logo of the Cass Review. The Independent Review of Gender Identity Services for Children and Young People (commonly, the Cass Review) was commissioned in 2020 by NHS England and NHS Improvement [1] and led by Hilary Cass, a retired consultant paediatrician and the former president of the Royal College of Paediatrics and Child Health. [2]

  3. Feminizing hormone therapy - Wikipedia

    en.wikipedia.org/wiki/Feminizing_hormone_therapy

    Feminizing hormone therapy, also known as transfeminine hormone therapy, is a form of gender-affirming care and a gender-affirming hormone therapy to change the secondary sex characteristics of transgender people from masculine to feminine.

  4. Gender-affirming hormone therapy - Wikipedia

    en.wikipedia.org/wiki/Gender-affirming_hormone...

    Gender-affirming hormone therapy (GAHT), also called hormone replacement therapy (HRT) or transgender hormone therapy, is a form of hormone therapy in which sex hormones and other hormonal medications are administered to transgender or gender nonconforming individuals for the purpose of more closely aligning their secondary sexual characteristics with their gender identity.

  5. Menopause and HRT: What you need to know, from the ... - AOL

    www.aol.com/menopause-hrt-know-risks...

    Some form of hormone replacement therapy now taken by over one million women in Britain. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ways ...

  6. Hormone replacement therapy and menopause: What you ... - AOL

    www.aol.com/hormone-replacement-therapy...

    Hormone replacement therapy ... The NHS prescribed 13 million HRT items to an estimated 2.6 million patients in 2023/24, up from just under 11m items for 2.3m women in 2022/23.

  7. Transgender health care - Wikipedia

    en.wikipedia.org/wiki/Transgender_health_care

    Hormone replacement therapy (HRT) is primarily concerned with alleviating gender dysphoria in transgender people. [17] Hormone therapy targets the secondary sex characteristics. Trans women typically use feminizing therapy, the goal of which is to develop female characteristics while suppressing male characteristics.

  8. Medical uses of bicalutamide - Wikipedia

    en.wikipedia.org/wiki/Medical_uses_of_bicalutamide

    Bicalutamide is used primarily in the treatment of early and advanced prostate cancer. [1] It is approved at a dosage of 50 mg/day as a combination therapy with a gonadotropin-releasing hormone analogue (GnRH analogue) or orchiectomy (that is, surgical or medical castration) in the treatment of stage D2 metastatic prostate cancer (mPC), [2] [3] and as a monotherapy at a dosage of 150 mg/day ...

  9. Pharmacists given greater freedoms to choose alternative HRT ...

    www.aol.com/pharmacists-given-greater-freedoms...

    For premium support please call: 800-290-4726 more ways to reach us